| AD | Alzheimer’s disease |
| AKT | A serine/threonine-specific protein kinase |
| ARE | Antioxidant response element |
| EPA | Environment Protection Agency |
| ESBL | Extended Spectrum Beta-Lactamases |
| Keap-1-Nrf2-ARE | Kelch-like erythroid cell-derived protein with CNC homology (ECH)-associated protein 1–anti-oxidant response element |
| AITC | Allyl isothiocyanate |
| GARDP | Global Antibiotic Research and Development Partnership |
| GSK | Glycogen Synthase Kinase |
| GST | Glutathione-S-transferase |
| DNDI | Drugs for Neglected Diseases initiative |
| IACG | Interagency Coordination Group on Antimicrobial Resistance |
| LPS | Lipopolysaccharide |
| MAPK | A mitogen-activated protein kinase |
| NFκB | Nuclear factor kappa light chain enhancer of activated B cells |
| NLRPR3 | Nucleotide-binding domain and leucine-rich repeat–containing protein 3 |
| NSAID | Non-Steroidal anti-inflammatory |
| PDGF | Platelet derived growth factor |
| ROS | Reactive oxygen species |
| SMC | Smooth muscle cell |
| TNF | Tumour necrosis factor-alpha |